Clinical Trials Browser

Phase 3 × Carcinoma × trifluridine tipiracil drug combination × Clear all

NCT04879368 2025-07-17

INTEGRATEIIb

Phase 3 Active not recruiting

Adenocarcinoma, Carcinoma, Neoplasm Metastasis

NCT03717038 2019-02-04

Sym004 Versus TAS-102 in Patients With mCRC

Phase 3 Withdrawn

Gastrointestinal

Carcinoma, Colorectal Neoplasms